Corporativo Fragua SAB de CV - Class B

NEW
MEX:FRAGUAB (Mexico)   Class B
MXN 447 -2.97 (-0.66%) Sep 10
9.36
P/B:
1.68
Market Cap:
MXN 42.80B ($ 2.52B)
Enterprise V:
MXN 40.22B ($ 2.37B)
Volume:
45.00
Avg Vol (2M):
5.20K
Trade In:

Business Description

Description
Corporativo Fragua SAB de CV is engaged in the drug retail sector in Mexico. The company operates a network of pharmacies under the Farmacias Guadalajara brand name, focusing on selling medicines, medical devices, and a variety of other products, including grocery items, exercise machines, perfumes, housewares, electronics, personal care products, toys, and photographic equipment.
Name Current Vs Industry Vs History
Cash-To-Debt
1.72
Equity-to-Asset
0.44
Debt-to-Equity
0.14
Debt-to-EBITDA
0.56
Interest Coverage
4.45
Piotroski F-Score
4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score
3.58
Distress
Grey
Safe
Beneish M-Score
-2.05
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI
47.7
9-Day RSI
45.45
14-Day RSI
44.73
3-1 Month Momentum %
1.08
6-1 Month Momentum %
-10.31
12-1 Month Momentum %
-11.49

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio
1.1
Quick Ratio
0.37
Cash Ratio
0.21
Days Inventory
77.14
Days Sales Outstanding
1.47
Days Payable
87.63

Dividend & Buy Back

Name Current Vs Industry Vs History
Dividend Yield %
3.18
Dividend Payout Ratio
0.27
3-Year Dividend Growth Rate
11
Forward Dividend Yield %
3.18
5-Year Yield-on-Cost %
16.32
3-Year Average Share Buyback Ratio
0.8
Shareholder Yield %
2.74
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Corporativo Fragua SAB de CV Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil MXN) 120,237.944
EPS (TTM) (MXN) 47.778
Beta -0.095
3-Year Sharpe Ratio -0.3
3-Year Sortino Ratio -0.41
Volatility % 19.26
14-Day RSI 44.73
14-Day ATR (MXN) 13.092571
20-Day SMA (MXN) 454.2965
12-1 Month Momentum % -11.49
52-Week Range (MXN) 420.01 - 600
Shares Outstanding (Mil) 95.74

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Corporativo Fragua SAB de CV Filings

Filing Date Document Date Form
No Filing Data

Corporativo Fragua SAB de CV Stock Events

Financials Calendars
Event Date Price (MXN)
MXN 14.300000 Cash Dividend 2026-03-30 498.00 (+2.05%)
MXN 14.300000 Cash Dividend 2025-04-25 527.00 (+0.06%)
Show
Entries

Corporativo Fragua SAB de CV Frequently Asked Questions

What is Corporativo Fragua SAB de CV(MEX:FRAGUAB)'s stock price today?
The current price of MEX:FRAGUAB is MXN447.00. The 52 week high of MEX:FRAGUAB is MXN600.00 and 52 week low is MXN420.01.
When is next earnings date of Corporativo Fragua SAB de CV(MEX:FRAGUAB)?
The next earnings date of Corporativo Fragua SAB de CV(MEX:FRAGUAB) is .
Does Corporativo Fragua SAB de CV(MEX:FRAGUAB) pay dividends? If so, how much?
The  Dividend Yield %  of Corporativo Fragua SAB de CV(MEX:FRAGUAB) is 3.18% (As of Today), Highest Dividend Payout Ratio of Corporativo Fragua SAB de CV(MEX:FRAGUAB) was 0.37. The lowest was 0.11. And the median was 0.17. The  Forward Dividend Yield % of Corporativo Fragua SAB de CV(MEX:FRAGUAB) is 3.18%. For more information regarding to dividend, please check our Dividend Page.

Press Release

Subject Date
No Press Release